Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pauline Soibinet
Observed names:
P. Soibinet,
Soibinet, Pauline
Institution:
Institut Jean Godinot
Observed institutions:
Centre Hospitalier Universitaire de Reims,
Centre François Baclesse,
Centre Antoine Lacassagne,
Institut Jean Godinot
OpenAlex ID:
A5021043436
Improved survival using specialized multidisciplinary board in sarcoma patients
2017
·
J.-Y. Blay
, P. Soibinet
, et al.
·
Annals of Oncology
·
392
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
2019
·
J.-Y. Blay
, C. Honoré
, et al.
·
Annals of Oncology
·
347
PDF
Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues
2015
·
Bertrand Brieau
, Laetitia Dahan
, et al.
·
Cancer
·
120
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
2023
·
Jean-Yves Blay
, Sylvie Chevret
, et al.
·
The Lancet Oncology
·
103
Improved nationwide survival of sarcoma patients with a network of reference centers
2024
·
J.Y. Blay
, N. Penel
, et al.
·
Annals of Oncology
·
55
PDF
Correction to: Surgery in reference centers improves survival of sarcoma patients: a nationwide study
2019
·
J.-Y. Blay
, C. Honoré
, et al.
·
Annals of Oncology
·
50
PDF
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
2024
·
Jean-Yves Blay
, Quentin Devin
, et al.
·
The Lancet Oncology
·
31
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years
2023
·
JY Blay
, S. Piperno-Neumann
, et al.
·
European Journal of Cancer
·
27
PDF
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study
2015
·
Bertrand Brieau
, Claire Auzolle
, et al.
·
Digestive and Liver Disease
·
25
Determinants of the access to remote specialised services provided by national sarcoma reference centres
2021
·
Yohan Fayet
, Raphaël Tétreau
, et al.
·
BMC Cancer
·
21
PDF
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years
2023
·
JY Blay
, C. Tlemsani
, et al.
·
European Journal of Cancer
·
17
PDF
Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis
2022
·
Francois Gouin
, Eberhard Stoeckle
, et al.
·
BMC Cancer
·
17
PDF
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks’ Outcome?
2022
·
Yohan Fayet
, Christine Chevreau
, et al.
·
Cancers
·
10
PDF
Clinical presentation, management and outcome of 11132 patients with liposarcoma: a population-based study from the NETSARC+ registry
2025
·
Jean-Yves Blay
, Maud Toulmonde
, et al.
·
The Lancet Regional Health - Europe
·
7
PDF
Improved Metastatic-Free Survival after Systematic Re-Excision Following Complete Macroscopic Unplanned Excision of Limb or Trunk Soft Tissue Sarcoma
2024
·
Francois Gouin
, Audrey Michot
, et al.
·
Cancers
·
7
PDF
Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial
2022
·
Lidia Delrieu
, Anne-Sophie Hamy
, et al.
·
BMC Cancer
·
4
PDF
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France
2026
·
Jean-Yves Blay
, Vincent Thevenet
, et al.
·
EClinicalMedicine
·
3
Improving Medical Education in Oncology: Enhancing Students’ Understanding of Cancer Treatments Through Multidisciplinary Clinical Rotations
2025
·
Arnaud Beddok
, Leila Bouazzi
, et al.
·
Journal of Cancer Education
·
2
Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.
2014
·
Bertrand Brieau
, Laetitia Dahan
, et al.
·
Journal of Clinical Oncology
·
2
Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors
2025
·
Aurore Devoldere
, Clélia Vanhaecke
, et al.
·
Acta Dermato Venereologica
·
1
PDF
Cancer de l’ovaire révélé par des métastases cutanées et une lymphangite carcinomateuse mammaires
2019
·
S. Stien
, J. Loget
, et al.
·
Annales de Dermatologie et de Vénéréologie
·
1
1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)
2015
·
A. Patsouris
, A.L. Septans
, et al.
·
European Journal of Cancer
·
1
Safety of concurrent T-DM1 and radiation therapy in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy
2026
·
Arnaud Beddok
, Laura Girres
, et al.
·
International Journal of Radiation Biology
4445 Safety of Concurrent TDM1 and Locoregional Radiotherapy in HER2-Positive Breast Cancer: A Retrospective Analysis
2025
·
Arnaud Beddok
, Laura Girres
, et al.
·
Radiotherapy and Oncology
Safety of Concurrent Administration of TDM1 and Radiotherapy in Patients with HER2+ Breast Cancer with Residual Disease Post-Neoadjuvant Chemotherapy
2024
·
L. Girres
, P. Torielli
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
35
Citation count:
1,243
H-index:
12
I10-index:
13
Year
Topic
Type